Healthcare and telemedicine stocks have delivered some of the market’s biggest winners in recent years, as investors bet on ...

Here’s the intriguing aspect of HIMS—it’s not performing like a conventional high-growth stock. At 7.6x trailing revenues, ...

Hims is a telehealth platform for men that offers virtual care for various health concerns. The platform addresses issues such as hair loss, sexual health, weight management, skincare and mental ...

Hims & Hers is emerging as a disruptive force in the obesity treatment market, challenging established GLP-1 drug makers.

Hims & Hers Health, Inc. HIMS launched a new specialty in women’s health last week. It offers access to affordable treatment ...

HIMS expects revenue growth to rebound, driven by weight loss and new health offerings, aiming for 30%+ growth in 2026. Read ...

My barber warned me about hair loss three decades ago. Investors should now take heed. The next biotech rally may sprout on ...

Hims & Hers HIMS stock jumped 12-16% after launching menopause care, but faces regulatory scrutiny and mixed analyst ratings.

Shares of Hims & Hers Inc. fell after hours on Monday after the wellness and telehealth platform's third-quarter forecast came up shy of Wall Street's estimates, although the company stuck with its ...